Table 4. .
Confirmed Cases of CIED Infection
Age, Race/Sex | Device | Arrhythmia and EF | Risk Factors | Cancer | Oncologic Therapy (Pre-CIED) | Oncologic Therapy (Post-CIED) | Laboratory Values (ANC/platelets) | IV Access | Antimicrobials to Prevent CIED Infection | Non-CIED Infection | CIED Infection and Management (Time From CIED Placement) |
---|---|---|---|---|---|---|---|---|---|---|---|
48 y, WM | PPM | Atrial flutter, third-degree heart block, 50% | 2 leads, oral antiplatelets, anticoagulation, PPM for 5 y prior, and CIED endocarditis | Hodgkin lymphoma | Mantle cell radiation, chemotherapy, splenectomy, and autologous HSCT | None | 5180 cells/μl352 cells/μl | PICC | (a) Preoperative vancomycin, (b) polymyxin B plus bacitracin pocket irrigation, (c) resorbable TYRX, (d) postoperative minocycline | Septic shock, pneumonia, and pneumococcal bacteremia | Lead infection (pneumococcus) status post–PPM exchange and 6 wk of antimicrobials (118 d) |
74 y, WF | CRT-D | Atrial fibrillation, 25% (chemotherapy-induced cardiomyopathy) | HTN, CAD, 3 leads, oral anticoagulation, ICD for 2 y prior | Invasive ductal breast carcinoma | Bilateral mastectomy, chest radiation, chemotherapy, and hormonal therapy | Chest radiation and hormonal therapy | 800 cells/μl224 cells/μl | None | (a) Preoperative vancomycin, (b) polymyxin B plus bacitracin pocket irrigation, (c) resorbable TYRX, (d) postoperative minocycline | Recurrent urinary tract infections | Generator infection (culture negative) status post CRT-D exchange and 2 weeks of antimicrobials (1174d) |
Abbreviations: ANC, absolute neutrophil count; CAD, coronary artery disease, CRT-D, cardiac resynchronization therapy defibrillator; EF, ejection fraction; HSCT, hematopoietic stem cell transplantation; HTN, hypertension; ICD, implantable cardio defibrillator; IV, intravenous; PICC, peripherally inserted central catheter; PPM, permanent pacemaker; W, White.